Sanofi, GSK to supply 60 million doses of potential COVID-19 vaccine to Britain
PARIS (FRANCE) - Sanofi and GSK have agreed to supply 60 million doses of a potential ...
Read morePARIS (FRANCE) - Sanofi and GSK have agreed to supply 60 million doses of a potential ...
Read moreFRANKFURT (Business) - There is a notable name missing from the frontrunners in the race to ...
Read more(Business) - GlaxoSmithKline Plc plans to expand vaccine efficacy boosters' production to produce one billion doses ...
Read more(Business) - GlaxoSmithKline announced that it agreed to sell all of its stake in Unilever's Indian ...
Read moreBritish drugmaker GlaxoSmithKline Plc is collaborating with the Coalition for Epidemic Preparedness Innovations (CEPI) to contribute ...
Read more